Vanda Pharmaceuticals Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.93

+0.03 (+0.51%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +160.5% upside

Low Target $11.33

Average Target $15.45

High Target $18.37

Current Price $5.93

Current
$5.93

Target
$15.45

$11.33 $15.45 avg $18.37

Scenario Analysis

Bear Case

$11.33

91.1%

Low target

Base Case

$15.45

+160.5%

Avg target

Bull Case

$18.37

+209.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$9.94

-40.3% from high

52-Week Low

$4.14

+43.2% from low

Target vs 52W High

$15.45

+55.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.0%